tirzepatide visceral fat loss gender differences Bridging the gap between GLP1-receptor agonists and cardiovascular outcomes: evidence for the role of | Cardiovascular Diabetology Tirzepatide: a novel therapeutic approach

All of this is relatively new

Regular Follow-up Schedule regular check-ups with your healthcare provider after discontinuing semaglutide

its effects build gradually over hours and days as plasma concentrations rise and the drug engages its target receptors

(8) Locatelli V, Bianchi VE

Pure GLP-1 receptor agonists work through four mechanisms: Slowed gastric emptying (the primary satiety signal) Increased insulin secretion in response to glucose Reduced glucagon secretion (glucagon raises blood sugar) Central appetite suppression via hypothalamic GLP-1 receptors The weight loss ceiling for pure GLP-1 agonists appears to be around 15% to 17% of baseline body weight at maximum tolerated dose over 68 weeks (the STEP 1 and STEP 5 trial endpoints for semaglutide 2.4 mg)